four approved frontline treatments benefit patients with chronic myeloid leukemia
Published 5 years ago • 192 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
1:59
comparing frontline therapies for the treatment of chronic myeloid leukemia
-
7:39
frontline treatment for cml with bcr-abl-targeted tkis
-
2:03
nilotinib benefits relapsed patients with cml after treatment discontinuation
-
10:40
treating the newly diagnosed patient with chronic myeloid leukemia
-
6:05
frontline treatment of chronic myelogenous leukemia
-
6:51
resistance to targeted-tki treatment in patients with cml
-
8:01
response monitoring of patients with cml treated with tkis
-
9:14
cml: frontline bcr-abl tki therapy
-
0:40
frontline treatment options available for patients with cll
-
5:22
bosutinib versus ponatinib in r/r cml
-
1:00
deciding the next steps for treating patients with acute myeloid leukemia
-
4:44
the deciding factors for cml treatment
-
7:32
cml as an ideal cancer for targeted therapy with tki
-
1:16
dr. mannis on targeted agents in the treatment of patients with aml
-
3:51
importance of compliance with tkis in treatment of cml
-
1:26
advice to community oncologists treating chronic myeloid leukemia
-
0:59
dr. hagop kantarjian on the optimal frontline treatment for cml
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
26:40
faster, better, safer—getting cml treatment right